• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

博茨瓦纳HIV-1 C亚型大流行早期和晚期病毒序列中HIV-1细胞毒性T淋巴细胞相关逃逸突变流行率无差异。

No Difference in the Prevalence of HIV-1 Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.

作者信息

Mokaleng Baitshepi, Choga Wonderful Tatenda, Bareng Ontlametse Thato, Maruapula Dorcas, Ditshwanelo Doreen, Kelentse Nametso, Mokgethi Patrick, Moraka Natasha Onalenna, Motswaledi Modisa Sekhamo, Tawe Leabaneng, Koofhethile Catherine Kegakilwe, Moyo Sikhulile, Zachariah Matshediso, Gaseitsiwe Simani

机构信息

Botswana Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone 999106, Botswana.

School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone 999106, Botswana.

出版信息

Vaccines (Basel). 2023 May 19;11(5):1000. doi: 10.3390/vaccines11051000.

DOI:10.3390/vaccines11051000
PMID:37243104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10221913/
Abstract

HIV is known to accumulate escape mutations in the gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur within an individual as well as at a population level. The population of Botswana exhibits a high prevalence of HLAB57 and HLAB58, which are associated with effective immune control of HIV. In this retrospective cross-sectional investigation, HIV-1 gene sequences were analyzed from recently infected participants across two time periods which were 10 years apart: the early time point (ETP) and late time point (LTP). The prevalence of CTL escape mutations was relatively similar between the two time points-ETP (10.6%) and LTP (9.7%). The P17 protein had the most mutations (9.4%) out of the 36 mutations that were identified. Three mutations (A83T, K18R, Y79H) in P17 and T190A in P24 were unique to the ETP sequences at a prevalence of 2.4%, 4.9%, 7.3%, and 5%, respectively. Mutations unique to the LTP sequences were all in the P24 protein, including T190V (3%), E177D (6%), R264K (3%), G248D (1%), and M228L (11%). Mutation K331R was statistically higher in the ETP (10%) compared to the LTP (1%) sequences ( < 0.01), while H219Q was higher in the LTP (21%) compared to the ETP (5%) ( < 0.01). Phylogenetically, the sequences clustered dependently on the time points. We observed a slower adaptation of HIV-1C to CTL immune pressure at a population level in Botswana. These insights into the genetic diversity and sequence clustering of HIV-1C can aid in the design of future vaccine strategies.

摘要

众所周知,人类免疫缺陷病毒(HIV)会针对细胞毒性T淋巴细胞(CTL)的免疫反应在基因中积累逃逸突变。这些突变既可能在个体内部发生,也可能在群体层面出现。博茨瓦纳人群中HLAB57和HLAB58的流行率很高,这两种基因与对HIV的有效免疫控制相关。在这项回顾性横断面调查中,对相隔10年的两个时间段内近期感染参与者的HIV-1基因序列进行了分析:早期时间点(ETP)和晚期时间点(LTP)。两个时间点——ETP(10.6%)和LTP(9.7%)——之间CTL逃逸突变的流行率相对相似。在已识别的36个突变中,P17蛋白的突变最多(9.4%)。P17中的三个突变(A83T、K18R、Y79H)和P24中的T190A是ETP序列特有的,流行率分别为2.4%、4.9%、7.3%和5%。LTP序列特有的突变都在P24蛋白中,包括T190V(3%)、E177D(6%)、R264K(3%)、G248D(1%)和M228L(11%)。突变K331R在ETP序列中的发生率(10%)在统计学上高于LTP序列(1%)(P<0.01),而H219Q在LTP序列中的发生率(21%)高于ETP序列(5%)(P<0.01)。从系统发育角度看,基因序列根据时间点聚类。我们观察到在博茨瓦纳的群体层面,HIV-1C对CTL免疫压力的适应性较慢。这些对HIV-1C基因多样性和序列聚类的见解有助于未来疫苗策略的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/6066bdf88901/vaccines-11-01000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/ff365865725b/vaccines-11-01000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/9d4a6a116f4b/vaccines-11-01000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/332cf3abc783/vaccines-11-01000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/6066bdf88901/vaccines-11-01000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/ff365865725b/vaccines-11-01000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/9d4a6a116f4b/vaccines-11-01000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/332cf3abc783/vaccines-11-01000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10221913/6066bdf88901/vaccines-11-01000-g004.jpg

相似文献

1
No Difference in the Prevalence of HIV-1 Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.博茨瓦纳HIV-1 C亚型大流行早期和晚期病毒序列中HIV-1细胞毒性T淋巴细胞相关逃逸突变流行率无差异。
Vaccines (Basel). 2023 May 19;11(5):1000. doi: 10.3390/vaccines11051000.
2
Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.常见细胞毒性T淋巴细胞驱动的病毒序列突变引起的HIV-1衣壳稳定性变化
J Virol. 2016 Jul 27;90(16):7579-7586. doi: 10.1128/JVI.00867-16. Print 2016 Aug 15.
3
Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.人类白细胞抗原相关的可变Gag蛋白逃逸突变的早期演变预示着HIV-1 C亚型感染女性的CD4+细胞下降。
AIDS. 2017 Jan 14;31(2):191-197. doi: 10.1097/QAD.0000000000001298.
4
Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.病毒复制能力与HLA B57/B5801相关的非进展性HIV-1感染的相关性
J Immunol. 2007 Sep 1;179(5):3133-43. doi: 10.4049/jimmunol.179.5.3133.
5
HIV-1C and Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana.HIV-1C 与博茨瓦纳 HIV 相关隐球菌性脑膜炎患者脑脊液和血浆中的变异。
Viruses. 2020 Dec 7;12(12):1404. doi: 10.3390/v12121404.
6
HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.在感染 CRF01_AE 的个体中,HLA 相关的免疫压力对 gag 蛋白的影响及其与血浆病毒载量的关系。
PLoS One. 2010 Jun 17;5(6):e11179. doi: 10.1371/journal.pone.0011179.
7
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.HLA-B*13相关逃逸突变对HIV-1复制及Nef功能的影响
J Virol. 2015 Nov;89(22):11557-71. doi: 10.1128/JVI.01955-15. Epub 2015 Sep 9.
8
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.适应性平衡逃逸决定了HIV-1感染中动态原始病毒逃逸过程的消退。
J Virol. 2015 Oct;89(20):10303-18. doi: 10.1128/JVI.01876-15. Epub 2015 Jul 29.
9
Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.突变对复制适应性和主要组织相容性复合体 I 结合亲和力的影响是导致 HIV-1 Gag 表位逃避细胞毒性 T 淋巴细胞的决定因素之一。
mBio. 2017 Nov 28;8(6):e01050-17. doi: 10.1128/mBio.01050-17.
10
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.HIV-1逃逸突变对细胞毒性T淋巴细胞(CTL)反应的适应性影响各异。
PLoS Pathog. 2009 Apr;5(4):e1000365. doi: 10.1371/journal.ppat.1000365. Epub 2009 Apr 3.

本文引用的文献

1
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.CTL 表位特异性在 HIV 治愈努力中的新作用。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):32-37. doi: 10.1093/infdis/jiaa333.
2
CD8 T cells in HIV control, cure and prevention.HIV 控制、治疗和预防中的 CD8 T 细胞。
Nat Rev Immunol. 2020 Aug;20(8):471-482. doi: 10.1038/s41577-020-0274-9. Epub 2020 Feb 12.
3
Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.横断面研究结果显示,在 2013-2015 年成功扩大抗逆转录病毒治疗规模的时代,博茨瓦纳农村社区的艾滋病毒发病率很高。
PLoS One. 2018 Oct 24;13(10):e0204840. doi: 10.1371/journal.pone.0204840. eCollection 2018.
4
Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants.系统进化模式再现了已知的 HIV 流行病学关系,并揭示了多种变异体的共同传播。
Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.
5
Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics.HIV 特异性 CTL 反应的动力学在决定 HIV 逃逸动力学方面作用很小。
Front Immunol. 2018 Feb 8;9:140. doi: 10.3389/fimmu.2018.00140. eCollection 2018.
6
Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.影响低收入和中等收入国家人类免疫缺陷病毒耐药性出现的关键因素
J Infect Dis. 2017 Dec 1;216(suppl_9):S851-S856. doi: 10.1093/infdis/jix409.
7
Role of HIV-specific CD8 T cells in pediatric HIV cure strategies after widespread early viral escape.广泛早期病毒逃逸后,HIV特异性CD8 T细胞在儿童HIV治愈策略中的作用。
J Exp Med. 2017 Nov 6;214(11):3239-3261. doi: 10.1084/jem.20162123. Epub 2017 Oct 5.
8
Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.撒哈拉以南非洲地区患者报告的抗逆转录病毒治疗依从性的障碍和促进因素。
AIDS. 2017 Apr 24;31(7):995-1007. doi: 10.1097/QAD.0000000000001416.
9
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.博茨瓦纳在实现 2020 年艾滋病署 90-90-90 抗逆转录病毒治疗和病毒学抑制目标方面的进展:一项基于人群的调查。
Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24.
10
Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance.博茨瓦纳产前诊所中通过药物传播的艾滋病毒耐药率急剧上升,这表明有必要进行常规监测。
J Antimicrob Chemother. 2016 May;71(5):1361-6. doi: 10.1093/jac/dkv500. Epub 2016 Feb 29.